Modern options in personalized therapy of metastatic cutaneous melanoma

A great progress was recently achieved in metastatic melanoma therapy. New targeted therapies allow high efficacy expectations for personalized treatment approaches. BRAF-inhibitors significantly increase time to progression, overall survival and response rate in malignant melanoma patients. Vemuraf...

Full description

Bibliographic Details
Main Authors: S A Protsenko, A V Novik, Z Yu Akhaeva, A S Zhabina, E N Imyanitov, A I Semenova
Format: Article
Language:Russian
Published: IP Habib O.N. 2014-09-01
Series:Современная онкология
Subjects:
Online Access:https://modernonco.orscience.ru/1815-1434/article/view/26968